Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vertex, Inc.

35.10
-0.3500-0.99%
Post-market: 35.100.00000.00%16:20 EDT
Volume:500.55K
Turnover:17.61M
Market Cap:5.56B
PE:-123.81
High:35.77
Open:35.77
Low:34.97
Close:35.45
Loading ...

Vertex price target lowered to $55 from $60 at Morgan Stanley

TIPRANKS
·
16 Apr

Vertex Minerals Highlights Gold Mining Prospects at Noosa Conference

TIPRANKS
·
15 Apr

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
15 Apr

Vertex to Announce First Quarter 2025 Financial Results on Wednesday, May 7, 2025

GlobeNewswire
·
15 Apr

Vertex Is Maintained at Buy by DA Davidson

Dow Jones
·
15 Apr

Vertex price target lowered to $50 from $55 at DA Davidson

TIPRANKS
·
14 Apr

Nasdaq Market Whiplash: 3 Stocks to Buy Hand Over Fist and Hold for Decades

Motley Fool
·
12 Apr

Pharma Tariffs Are Coming. Investors Underestimate the Risk. -- Barrons.com

Dow Jones
·
12 Apr

Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis

Business Wire
·
11 Apr

Vertex Pharmaceuticals (VRTX) Stock Moves -1.41%: What You Should Know

Zacks
·
11 Apr

Vertex Pharmaceuticals Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
11 Apr

Analysts’ Top Technology Picks: Microsoft (MSFT), Vertex (VERX)

TIPRANKS
·
10 Apr

Vertex Expands Chief Strategy Office to Advance E-Invoicing and Global Compliance Initiatives

GlobeNewswire
·
10 Apr

We're About to Find Out the Answer to Warren Buffett's Pointed Question About Trump's Tariffs. Here Are 3 Stocks to Buy Depending on What That Answer Is.

Motley Fool
·
10 Apr

Vertex Pharmaceuticals Inc. Stock Rises Wednesday, Still Underperforms Market

Dow Jones
·
10 Apr

Morgan Stanley Adjusts PT on Vertex Pharmaceuticals to $462 From $459, Keeps Equalweight Rating

MT Newswires Live
·
09 Apr

Morgan Stanley Remains a Hold on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
09 Apr

Vertex Pharmaceuticals price target raised to $462 from $459 at Morgan Stanley

TIPRANKS
·
09 Apr

NetApp Partners With Google Cloud to Simplify Scaling High-Performance Workloads in the Cloud

Business Wire
·
09 Apr

Jim Cramer Calls Vertex Pharmaceuticals Incorporated (VRTX) “Terrific” With “Revolutionary Pain Drug”

Insider Monkey
·
09 Apr